Arsenic Trioxide in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
NCT00075426
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Lung Cancer
Interventions
DRUG:
arsenic trioxide
Sponsor
The University of Texas Medical Branch, Galveston